Virologic and CD4+ cell responses to new nucleoside regimens: Switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection

D. A. Katzenstein*, M. Hughes, M. Albrecht, S. Hammer, M. Para, R. Murphy, H. Valdez, R. Haubrich, S. Liou

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Virologic and CD4+ cell responses to new nucleoside regimens: Switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

INIS